RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Inflation Reduction Act (IRA) boosts biological drugs Pearl Bio's whiteboards ideas have been developed over 15 years.
Pearl is pioneering a new era of biotherapeutic design by seeking enabling access to potential new disease targets and the putative evolution of entirely new classes of molecules.
Today MSD has announced it has decided to invest US$1 Billion in this start-up pseud0-biologicis company.